Anika Therapeutics | 販売および管理費



Selling And Administration Expenses 変化する 日付
Abbott USD 3.05B 144M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Arrowhead Research USD 27.89M 2.3M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Insmed USD 147.54M 5.03M 2025-03
Integra LifeSciences USD 164M 5.61M 2025-03
J&J USD 5.11B 1.34B 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Merit Medical Systems USD 107.49M 4.91M 2025-03
Sanofi EUR 2.22B 980M 2025-03
Smith & Nephew USD 1.35B 12.8M 2024-12
Stryker USD 2.3B 272M 2025-03
Veracyte USD 59.16M 8.45M 2025-03
Xencor USD 17.34M 2.42M 2025-03
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Anika Therapeutics 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.